|
|
|
Insider
Information: |
Sato Vicki L |
Relationship: |
|
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
1,670,897 |
|
Indirect Shares
|
8,084 |
|
|
Direct
Value |
$40,918,225 |
|
|
Indirect Value
|
$3,617,833 |
|
|
Total
Shares |
1,678,981 |
|
|
Total
Value |
$44,536,057 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
President |
2005-05-11 |
77,233 |
2005-05-11 |
8,084 |
Premium* |
|
Perkinelmer Inc |
PKI |
Director |
2017-02-09 |
29,970 |
2004-04-27 |
0 |
Premium* |
|
Infinity Pharmaceuticals Inc |
INFI |
Director |
2006-09-12 |
11,051 |
2006-09-12 |
0 |
Premium* |
|
Borgwarner Inc |
BWA |
Director |
2020-04-29 |
19,823 |
2014-04-30 |
0 |
Premium* |
|
Denali Therapeutics Inc. |
DNLI |
Director |
2024-05-15 |
116,369 |
2017-12-12 |
0 |
Premium* |
|
Vir Biotechnology, Inc. |
VIR |
Director |
2023-06-30 |
1,315,351 |
|
0 |
Premium* |
|
Allogene Therapeutics, Inc. |
ALLO |
|
2023-06-13 |
101,100 |
2021-07-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
227 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 10
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-05-06 |
4 |
A |
$0.01 |
$875 |
D/D |
87,500 |
188,108 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-10-20 |
4 |
OE |
$9.50 |
$5,605 |
D/D |
590 |
108,698 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-10-20 |
4 |
AS |
$10.50 |
$6,195 |
D/D |
(590) |
108,108 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-02-18 |
4 |
OE |
$6.00 |
$16,146 |
D/D |
2,691 |
104,408 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-10-13 |
4 |
OE |
$9.50 |
$19,950 |
D/D |
2,100 |
110,208 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-10-13 |
4 |
AS |
$10.56 |
$22,176 |
D/D |
(2,100) |
108,108 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-02-25 |
4 |
OE |
$6.00 |
$22,800 |
D/D |
3,800 |
111,533 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-03-03 |
4 |
OE |
$6.00 |
$22,800 |
D/D |
3,800 |
104,408 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-03-10 |
4 |
OE |
$6.00 |
$22,800 |
D/D |
3,800 |
104,408 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-03-17 |
4 |
OE |
$6.00 |
$22,800 |
D/D |
3,800 |
104,408 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-03-24 |
4 |
OE |
$6.00 |
$22,800 |
D/D |
3,800 |
104,408 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-03-31 |
4 |
OE |
$6.00 |
$22,800 |
D/D |
3,800 |
104,408 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
|
2003-09-10 |
4 |
OE |
$7.88 |
$27,509 |
D/D |
3,491 |
107,145 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
|
2003-07-02 |
4 |
OE |
$7.88 |
$29,944 |
D/D |
3,800 |
107,454 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
|
2003-07-09 |
4 |
OE |
$7.88 |
$29,944 |
D/D |
3,800 |
107,454 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
|
2003-07-16 |
4 |
OE |
$7.88 |
$29,944 |
D/D |
3,800 |
107,454 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
|
2003-07-23 |
4 |
OE |
$7.88 |
$29,944 |
D/D |
3,800 |
107,454 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
|
2003-07-30 |
4 |
OE |
$7.88 |
$29,944 |
D/D |
3,800 |
107,454 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
|
2003-09-17 |
4 |
OE |
$7.88 |
$29,944 |
D/D |
3,800 |
100,408 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
|
2003-09-24 |
4 |
OE |
$7.88 |
$29,944 |
D/D |
3,800 |
100,408 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2003-11-05 |
4 |
OE |
$7.88 |
$29,944 |
D/D |
3,800 |
100,408 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2003-11-12 |
4 |
OE |
$7.88 |
$29,944 |
D/D |
3,800 |
100,408 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2003-11-19 |
4 |
OE |
$7.88 |
$29,944 |
D/D |
3,800 |
100,408 |
|
- |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2024-04-15 |
4 |
AS |
$18.29 |
$30,471 |
D/D |
(1,666) |
118,043 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2024-02-15 |
4 |
AS |
$18.37 |
$30,604 |
D/D |
(1,666) |
121,375 |
0 |
% |
|
227 Records found
|
|
Page 2 of 10 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|